KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.13 USD
+0.05 (2.40%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $2.12 -0.01 (-0.47%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
KORU Medical Systems Inc. (KRMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.38 | $4.00 | $2.50 | 62.50% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for KORU Medical Systems Inc. comes to $3.38. The forecasts range from a low of $2.50 to a high of $4.00. The average price target represents an increase of 62.5% from the last closing price of $2.08.
Analyst Price Targets (4 )
Broker Rating
KORU Medical Systems Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/14/2024 | B. Riley Securities | William Wood | Strong Buy | Strong Buy |
3/1/2024 | Piper Sandler | Jason Bednar | Strong Buy | Strong Buy |
12/7/2023 | Canaccord Genuity | Caitlin Cronin | Not Available | Strong Buy |
9/7/2023 | Lake Street Capital Markets | Frank Takkinen | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $3.38 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 98 of 252 |
Current Quarter EPS Est: | -0.04 |